Correlation Between Silo Pharma and Marizyme
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Marizyme, you can compare the effects of market volatilities on Silo Pharma and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Marizyme.
Diversification Opportunities for Silo Pharma and Marizyme
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Silo and Marizyme is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Silo Pharma i.e., Silo Pharma and Marizyme go up and down completely randomly.
Pair Corralation between Silo Pharma and Marizyme
Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Marizyme. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 4.02 times less risky than Marizyme. The otc stock trades about -0.01 of its potential returns per unit of risk. The Marizyme is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 4.00 in Marizyme on September 3, 2024 and sell it today you would earn a total of 1.00 from holding Marizyme or generate 25.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Silo Pharma vs. Marizyme
Performance |
Timeline |
Silo Pharma |
Marizyme |
Silo Pharma and Marizyme Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Silo Pharma and Marizyme
The main advantage of trading using opposite Silo Pharma and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.Silo Pharma vs. Protagenic Therapeutics | Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals |
Marizyme vs. NRx Pharmaceuticals | Marizyme vs. RenovaCare | Marizyme vs. Aerovate Therapeutics | Marizyme vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |